Mexiletine in the Treatment of LQT2, LQT3, and Acquired LQTS: A Meta-Analysis
Background: High mortality in patients with Long QT Syndrome (LQTS) can be reduced with proper treatment. Gene-specific therapy is crucial, as many treatments are not equally effective across different LQTS types. While mexiletine has been established in the treatment of LQT3, its use in other type...
| الحاوية / القاعدة: | Majalah Kardiologi Indonesia |
|---|---|
| المؤلفون الرئيسيون: | , , , , , , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
Indonesian Heart Association
2025-05-01
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ijconline.id/index.php/ijc/article/view/1835 |
